Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

Most lung cancers are classified as either non-small cell lung cancer (NSCLC) or small-cell lung cancer (SCLC). SCLC is less common but tends to be more aggressive. It’s subdivided into two main types ...

Multidisciplinary evaluation, including thoracic surgical consultation, is crucial for oligometastatic NSCLC patients to optimize treatment strategies. Lung surgery for oligometastatic NSCLC shows ...

Squamous cell lung cancer starts in the squamous cells: thin, flat cells that line the inside of the airways in your lungs. If you're diagnosed after the cancer has spread, it tends to be more ...

Getting a diagnosis of lung cancer can be scary, especially when you don't know what to expect. To help, experts will guide ...

Lung (pulmonary) sarcoma is a rare type of lung cancer. Most lung cancers start in epithelial cells that line your airways, but pulmonary sarcoma develops in connective tissue or other nonepithelial ...

A recent Scientific Reports study discusses the development of an artificial intelligence (AI) prognostic model for surgically resected non-small cell lung cancer (NSCLC). Study: Development of ...

Under current screening guidelines, almost two-thirds of Americans with lung cancer would not have qualified for required ...

CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...

If you or a loved one has lung cancer, you may be interested in learning more about medicines used to treat it. One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy ...